Past Events
38 results
Applied filters
Primary care discussions: biosimilar insulin
30 September 2025Discussion about the considerations of implementing biosimilar insulin in primary care. Hints and tips for systems considering a move to biosimilar insulin.
MSATS – Safe use of medicines in palliative and end of life care
24 September 2025Discussion of medication safety challenges within palliative and end of life care; inspiring partnership across the system.
Health and Justice Medicines Optimisation 2025 Update
3 July 2025Sharing the latest developments in Health and Justice medicines optimisation and pharmacy services.
MSATS – Safe use of valproate
28 February 2024Discussion of key current medication safety challenges within healthcare with a focus on the safe use of valproate; inspiring partnership across the system
Social prescribing and pharmacy - an ‘on the couch’ conversation
12 September 2023An opportunity to hear how a social prescriber and pharmacist work together in primary care, with hints and ideas on how to reach out and collaborate
Navigating difficult conversations with confidence
5 June 2024This event explored why conversations with patients and colleagues can be challenging. Speakers shared insights and strategies to enhance confidence.
Primary care discussions: Heart failure
20 August 2024A practical discussion between two pharmacists with an interest in heart failure about identifying heart failure and optimising treatment in primary care.
Supporting pharmacists with HRT decision making
13 March 2024This webinar, the first in a series of two, provided an overview of the menopause with a focus around the selection, optimising and stopping of HRT.
MSATS - Safe Use of DOACs
30 October 2024Discussion of key current medication safety challenges within healthcare with a focus on the safe use of DOACs; inspiring partnership across the system.
Managing chronic liver disease in primary care
27 April 2023A practical ‘On the Couch’ discussion to help primary care pharmacy professionals appropriately manage patients with chronic liver disease in the community.